文献
J-GLOBAL ID:202002242041831812
整理番号:20A0535712
硫化水素放出抗炎症薬の消化管安全性の概念実証,第2相臨床試験【JST・京大機械翻訳】
A proof-of-concept, Phase 2 clinical trial of the gastrointestinal safety of a hydrogen sulfide-releasing anti-inflammatory drug
著者 (12件):
Wallace John L.
(Department of Physiology and Pharmacology, University of Calgary, Calgary, AB, Canada)
,
Wallace John L.
(Antibe Therapeutics Inc., Toronto, ON, Canada)
,
Nagy Peter
(National Institute of Oncology, Budapest, Hungary)
,
Nagy Peter
(Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
,
Feener Troy D.
(Department of Biological Sciences, University of Calgary, Calgary, AB, Canada)
,
Allain Thibault
(Department of Biological Sciences, University of Calgary, Calgary, AB, Canada)
,
Ditroi Tamas
(National Institute of Oncology, Budapest, Hungary)
,
Vaughan David J.
(Antibe Therapeutics Inc., Toronto, ON, Canada)
,
Muscara Marcelo N.
(Department of Pharmacology, University of Sao Paulo, Sao Paulo, Brazil)
,
de Nucci Gilberto
(Department of Pharmacology, University of Campinas, Campinas, Brazil)
,
Buret Andre G.
(National Institute of Oncology, Budapest, Hungary)
,
Buret Andre G.
(Department of Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
資料名:
British Journal of Pharmacology
(British Journal of Pharmacology)
巻:
177
号:
4
ページ:
769-777
発行年:
2020年
JST資料番号:
B0334A
ISSN:
0007-1188
CODEN:
BJPCB
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)